Form C/A Social. 121 LLC

  
    C/A
    
      
        
          0001942487
          XXXXXXXX
        
        020-30687
      
      LIVE
      
        false
        false
        false
      
    
  
  
    
      true
      Target end date updated
      
        Social. 121 LLC
        
          Limited Liability Company
          GA
          10-21-2021
        
        
          1579 MONROE DRIVE
          SUITE F197
          ATLANTA
          GA
          30324
        
        www.Social121Atl.com
      
      N
      Honeycomb Portal LLC
      0001705726
      007-00119
      289015
    
    
      Applied at marginal rate based upon amount of total offering: up to$50,000 = 8.0%, $50,001 - $100,000 = 7.0%, $100,001+ = 6.0%. $250 posting fee. 2.85% investment fee capped at $37.25.
      None
      Debt
      1.00000
      Pro-rated portion of the total principal
      25000.00
      Y
      First-come, first-served basis
      75000.00
      09-30-2022
    
    
      5.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      PR
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
      A0
      A1
      A2
      A3
      A4
      A5
      A6
      A7
      A8
      A9
      B0
      Z4
    
    
      
        Social. 121 LLC
        James Brashears III
        President
      
      
        
          James Brashears III
          President
          08-16-2022
        
      
    
  

You May Also Be Interested In

• GFG Closes Private Placement Financing
• NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
• The Central and Eastern Europe Fund, Inc. and The New Germany Fund, Inc. Announce Annual Meetings of Stockholders